EyeDura Therapeutics
PrivateCompany Overview
EyeDura Therapeutics Inc. is a biotechnology company developing preservative-free topical sustained-release eye drops that target both anterior and posterior segment diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EyeDura Therapeutics Comparables
Compare EyeDura Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BIOPHTA | 70% | |
| INEYE THERAPEUTICS S.A. | 65% | |
| Dompé | 64% |
EyeDura Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2025
Preclinical efficacy studies initiated for novel insulin drop treatment.
- Oct 10, 2025
Partnered with Singapore Eye Research Institute for preclinical efficacy studies.
EyeDura Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EyeDura Therapeutics's valuation, stock price, and market status.
Is EyeDura Therapeutics a public or private company?
EyeDura Therapeutics is a private company.
What is the current stock price of EyeDura Therapeutics?
EyeDura Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is EyeDura Therapeutics worth (valuation)?
Valuation information for EyeDura Therapeutics is not publicly available.
Can I buy EyeDura Therapeutics stock?
EyeDura Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EyeDura Therapeutics's last funding round?
Funding round information for EyeDura Therapeutics is not publicly available.
Who are the main investors in EyeDura Therapeutics?
Investor information for EyeDura Therapeutics is not publicly disclosed.
Will EyeDura Therapeutics IPO soon?
No public IPO plans have been announced for EyeDura Therapeutics.
How can I track EyeDura Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EyeDura Therapeutics's secondary market activity and sign up for updates.